Recombinant GP6 (Glenzocimab Biosimilar) antibody

Catalog No. ABIN7491015

The Humanized Monoclonal anti-GP6 (Glenzocimab Biosimilar) antibody has been validated for FACS. It is suitable to detect GP6 (Glenzocimab Biosimilar) in samples from Human.

Quick Overview for Recombinant GP6 (Glenzocimab Biosimilar) antibody (ABIN7491015)

Target: GP6 (Glenzocimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This GP6 (Glenzocimab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-GP6 (Glenzocimab Biosimilar) Antibody

Purpose: Anti-GP6 (glenzocimab biosimilar) mAb

Characteristics: ACT-017, ACT017

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Application Details

Application Notes: Flow Cyt 1:100

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for GP6 (Glenzocimab Biosimilar)

Target: GP6 (Glenzocimab Biosimilar)

Target Type: Biosimilar

Background: Synonyms: Glycoprotein 6, GPVI

UniProt: Q9HCN6